Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19.

Jurisic, Stjepan; Komminoth, Mathis; Todorov, Atanas; Bertschi, Daniela A; Jurisic, Martin; Vranjic, Ivica; Wiggli, Benedikt; Schmid, Hansruedi; Gebhard, Catherine; Gebhard, Caroline E; Heidecker, Bettina; Beer, Jürg-Hans; Patriki, Dimitri (2023). Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19. Journal of clinical medicine, 12(8) MDPI 10.3390/jcm12082925

[img]
Preview
Text
Long-Term_Mortality_after_New-Onset_Atrial_Fibrillation_in_COVID-19.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Background: Atrial fibrillation (AF) has been described as a common cardiovascular manifestation in patients suffering from coronavirus disease 2019 (COVID-19) and has been suggested to be a potential risk factor for a poor clinical outcome. Methods: In this observational study, all patients hospitalized due to COVID-19 in 2020 in the Cantonal Hospital of Baden were included. We assessed clinical characteristics, in-hospital outcomes as well as long-term outcomes with a mean follow-up time of 278 (±90) days. Results: Amongst 646 patients diagnosed with COVID-19 (59% male, median age: 70 (IQR: 59-80)) in 2020, a total of 177 (27.4%) patients were transferred to the intermediate/intensive care unit (IMC/ICU), and 76 (11.8%) were invasively ventilated during their hospitalization. Ninety patients (13.9%) died. A total of 116 patients (18%) showed AF on admission of which 34 (29%) had new-onset AF. Patients with COVID-19 and newly diagnosed AF were more likely to require invasive ventilation (OR: 3.5; p = 0.01) but did not encounter an increased in-hospital mortality. Moreover, AF neither increased long-term mortality nor the number of rehospitalizations during follow-up after adjusting for confounders. Conclusions: In patients suffering from COVID-19, the new-onset of AF on admission was associated with an increased risk of invasive ventilation and transfer to the IMC/ICU but did not affect in-hospital or long-term mortality.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Gebhard, Cathérine Simone

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2077-0383

Publisher:

MDPI

Language:

English

Submitter:

Tanja Gilgen

Date Deposited:

03 Jan 2024 09:14

Last Modified:

03 Jan 2024 09:14

Publisher DOI:

10.3390/jcm12082925

PubMed ID:

37109261

Uncontrolled Keywords:

COVID-19 atrial fibrillation outcome

BORIS DOI:

10.48350/190934

URI:

https://boris.unibe.ch/id/eprint/190934

Actions (login required)

Edit item Edit item
Provide Feedback